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Tight normoglycaemia improves medical prognosis of acute coronary syndromes {ACS).Therefore,
detection of hyperglycaemic deviations is crucial to initiate and adapt insulin therapy in patients who
are naive for diabetes with no high blood glucose when admitted.
We evaluated the ability to identifytime spent over 140 mgldl (TS> 140) by using a continuous glucose
monitoring device in a series of patients admitted in ICU for ACS.The secondary objective was to look
for predictive factors of hyperglycemia.
A subcutaneous glucose sensor connected to a portable monitor (CGMS', MiniMed-Medtronic) was
used in 2l patients (17 M/ 4F), aged 60 + 13, with a BMI of 26 + 3 kg/m'z, admitted in ICU since less
than 48 hours. Average timÊ of recording wâs 40 hours per patient (2400 mini. Sensor calibrations
were performed against the 4 daily capillary blood glucose (CBG) measurements checked in clinical
routine.
From a cumulated recording time of 50410 min, sensor data showed a TS> i40 of 9565 min (17o/o of
total time). Although a significant correlation appeared between the number of CBG values >140
mgldl and TS>140 mg/dl (r = 0.93; p< 0.û01), only 22/136 CBG values were >i40 mg/dl in patients
presenting some time >140 mg/dl (n=17)" No significant correlation between TS>140 mg/dl and age,
sex, BMI or family history of CV disease or diabetes was disclosed. From a multivariate analysls, the
model shows only a trend for BMI as a predictive factor for hyperglycaemia (p=O.oSe; B coefficient=
o.42).
Our results show a better atrility for CGMS" to detect hyperglycaemic periods than routine CBG
measurements in non diabetic patients, showing no high blood glucose when admitted for ACS.
Because no clear predictive facTor for hyperglycaemic deviations could be pointed out, continuous
glucose monitoring looksvaluable in such patients.Recentlydeveloped continuous glucose monitoring
devices providing real time data might be useful tools to track and manage hyperglycaemia in ACS.
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